[HTML][HTML] Low-molecular-weight heparins as adjunctive therapy to thrombolytics: extracting the best data

AL Bailey, SR Steinhubl - CMAJ, 2006 - Can Med Assoc
Thrombolysis alone restores coronary flow completely in only about half of patients so
treated. tients who did not undergo revascularization. The reason for this is not entirely clear …

Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind …

DP De Bono, ML Simoons, J Tijssen, AE Arnold… - Heart, 1992 - heart.bmj.com
OBJECTIVE--To determine whether concomitant treatment with intravenous heparin affects
coronary patency and outcome in patients treated with alteplase thrombolysis for acute …

Low-molecular-weight heparins in acute coronary syndrome: acquired results and new perspectives

F Ugo, D Ardissino - Giornale Italiano di Cardiologia (2006), 2006 - europepmc.org
Plaque disruption and thrombosis are the most important pathogenetic mechanisms of acute
coronary syndrome (ACS). Although unfractionated heparin (UFH) was the standard …

Fractionating Heparins and Their Clinical Trial Data—Something for Everyone

P Das, DJ Moliterno - JAMA, 2004 - jamanetwork.com
HEPARIN, A GLYCOSAMINOGLYCAN OF VARYING POLY-saccharide units and molecular
weights, has been shown to reduce ischemic events beyond that of aspirin alone in the …

[CITATION][C] Superiority of enoxaparin over unfractionated heparin for the treatment of acute coronary syndromes

M Cohen, EM Antman - Pharmacotherapy: The Journal of …, 2002 - Wiley Online Library
A recent article by Drs. Noviasky and Gaffney questioned the evidence for the use of the
lowmolecular-weight heparin (LMWH) enoxaparin versus the use of unfractionated heparin …

Low‐molecular‐weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke

PAG Sandercock, TS Leong - Cochrane Database of …, 2017 - cochranelibrary.com
Background Low‐molecular‐weight heparins (LMWHs) and heparinoids are anticoagulants
that may have more powerful antithrombotic effects than standard unfractionated heparin …

The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke

IC Kiphuth, M Köhrmann, HB Huttner… - Expert Opinion on …, 2009 - Taylor & Francis
Stroke is a common cause for morbidity and mortality, causing substantial economic costs.
Because thrombosis plays a key role in the pathogenesis of ischaemic stroke, heparins …

Low-molecular heparins in thrombolytic therapy of myocardial infarction patients

IS Yavelov - Cardiovascular Therapy and Prevention, 2009 - cardiovascular.elpub.ru
Currently, parenteral anticoagulant therapy is considered a standard addition to thrombolytic
treatment (TLT) in myocardial infarction (MI). This review analyses the results of the clinical …

ExTRACT-TIMI 25 in perspective: key lessons regarding enoxaparin as an adjunct to fibrinolytic therapy

D Thomas, RP Giugliano - Journal of thrombosis and thrombolysis, 2009 - Springer
Unfractionated heparin (UFH) for 48 h has been the traditional standard anticoagulant with
fibrinolytics. The Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction …

Enoxaparin Beats Heparin as Adjunct in Acute MI

ML ZOLER - Internal Medicine News, 2006 - cdn.mdedge.com
ATLANTA—The low-molecular-weight heparin enoxaparin was more effective than
unfractionated heparin as an adjunct to fibrinolytic therapy in patients with an acute …